GETINGE

An expanding Medical-Technology group with

focus on comprehensive solutions for infection

control, surgical systems and care of elderly and

disabled people

Customers

Net SalesAssociatesManufacturingDistribution

Acute CareLong term care Industry/Laboratories8.1 billion SEK5 30018 production units in 9 countries80 sales companies in 25 countries Distributors in I00 countries

Infection Control Infection Control Sterilization Disinfection

40%40%

Industry

I0% Acute care

60%Long term care 30%

Surgical SystemsSurgical SystemsSurgical tables Surgical lamps

30%30%

Bu

sin

es

s A

rea

sB

us

ine

ss

Are

as

Cu

sto

me

r s

eg

me

nts

Cu

sto

me

r s

eg

me

nts

Business Scope Business Scope

Extended CareExtended CareHygiene Systems Patient Handling

Wound Care 30%30%

Getinge Group ObjectivesGetinge Group Objectives

FinancialFinancialTo increase profit before tax with an To increase profit before tax with an

average of I5% per annumaverage of I5% per annumInternally generated cash flow to Internally generated cash flow to

sustain an external growth rate of I0% sustain an external growth rate of I0% per annumper annum

StrategicStrategicTo develop world leading positions in To develop world leading positions in

prioritized niches of the health care prioritized niches of the health care industryindustry

Infection ControlInfection ControlTo create a customer focused group from afederation of companies acquired over the

last I0years

Extended CareExtended CareFocus on growth from a solid platformthrough product innovation, market

penetrationand geographical expansion

Surgical SystemsSurgical SystemsTo create a global leader in the field of

surgicalwork stations as a platform for further

growth in the surgical systems market

Group Focus 2002 - 2004Group Focus 2002 - 2004

Business Area Extended Business Area Extended CareCare

Patient Patient HandlingHandling

Hygiene SystemsHygiene Systems

Complete solutions for institutional extended care:

Nursing Homes, Hospitals, Assisted Living

Wound CareWound Care

Strategic CornerstonesStrategic Cornerstones

Product leadershipProduct leadershipComplete solutionsComplete solutionsPositive outcomesPositive outcomes

Extended CareExtended CareMarket development Q1 (msek)Market development Q1 (msek)

2002 2001 Change 2002 2001 Changeper market Q 1 Q 1 3 Mon 3 MonUSA and Canada 249 240 4% 249 240 4%Great Britain 201 207 -3% 201 207 -3%Germany 73 69 6% 73 69 6%Other W Europe 153 161 -5% 153 161 -5%Rest of the world 20 20 -2% 20 20 -2%Business area tot. 695 696 0% 695 696 0%

Extended CareExtended CareResults Q1 (msek)Results Q1 (msek)

2002 2001 2002 2001 2001Q 1 Q 1 3 Mon 3 Mon F Y

Net sales 692 663 692 663 2,656 Gross margin % 53.0% 48.9% 53.0% 48.9% 49.2%Operating cost -240 -210 -240 -210 -886 Operating profit 127 115 127 115 421 Operating margin % 18.3% 17.3% 18.3% 17.3% 15.9%

Business area Infection Control Business area Infection Control Health CareHealth Care

DisinfectionDisinfection IT-solutionsIT-solutionsSterilizationSterilization Load Load handlinghandling

Complete Systems for:

Central Processing Departments, Outpatient Surgery, Wards,

Infectious Waste, Microbiology, Pharmacies

Load Load HandlingHandling

WashinWashing g

SterilizatiSterilizationon

Water Water TreatmentTreatment

Complete Systems for:

Production, Research / Laboratories, Animal Care Facilities, Food Industry

Business area Infection Control Business area Infection Control IndustryIndustry

Moving up the Value chainMoving up the Value chain

Service

Provider

Concept

Service

Provider

Concept

Complete

Infection

Control

Solution

Complete

Infection

Control

Solution

SterilizerSterilizerDisinfectorDisinfector

Load handlingLoad handlingLogisticsLogistics

ConsumablesConsumablesInformation Information

ManagementManagementAfter Sales serviceAfter Sales service

EducationEducation

SterilizerSterilizerDisinfectorDisinfector

Load handlingLoad handlingLogisticsLogistics

ConsumablesConsumablesInformation Information

ManagementManagementAfter Sales serviceAfter Sales service

EducationEducation

Strategic CornerstonesStrategic Cornerstones

Cost leadershipCost leadershipComplete solutionsComplete solutions

Service infrastructureService infrastructure

Position the Getinge brand as a Position the Getinge brand as a competent solutions providercompetent solutions provider

Improved production structureImproved production structureOrganizational focusOrganizational focus

Increased focus on R & D Increased focus on R & D - low temp - low temp solutionssolutions

- material - material handling handling

- ergonomy - ergonomy

Service expansionService expansion

Key Activities 2002 - 2003Key Activities 2002 - 2003

Infection ControlInfection ControlMarket development Q1 (msek)Market development Q1 (msek)

2002 2001 Change 2002 2001 Changeper market Q 1 Q 1 3 Mon 3 MonWestern Europe 375 344 9% 375 344 9%USA and Canada 325 299 9% 325 299 9%Asia/Australia 66 63 5% 66 63 5%Rest of the world 36 25 46% 36 25 46%Business area total 803 731 10% 803 731 10%

Infection ControlInfection ControlResults Q1 (msek)Results Q1 (msek)

2002 2001 2002 2001 2001Q 1 Q 1 3 Mon 3 Mon F Y

Net sales 689 682 689 682 3,204 Gross margin % 36.7% 35.7% 36.7% 35.7% 36.0%Operating cost -222 -192 -222 -192 -833 Operating profit 31 51 31 51 321 Operating margin % 4.4% 7.5% 4.4% 7.5% 10.0%

Business area Surgical SystemsBusiness area Surgical Systems

Surgical LightsSurgical LightsSurgical Surgical TablesTables

Ceiling Service Ceiling Service SystemsSystems

Integrated Solutions for Surgical Workstations and ICU’s

Strategic CornerstonesStrategic Cornerstones

Technological leadershipTechnological leadershipIntegrated solutionsIntegrated solutionsExcellence in serviceExcellence in service

ProductionProductionClosure of production facilities in CharlestonClosure of production facilities in Charleston

USA and Oer-Erkenschwick GermanyUSA and Oer-Erkenschwick Germany

DistributionDistributionMerger of sales activities in Germany, USA, Merger of sales activities in Germany, USA,

UK,UK,France, Italy, Spain, Japan and InternationalFrance, Italy, Spain, Japan and International

Reduced overhead costsReduced overhead costs

Synergies of I40 - I50 MSEK annually Synergies of I40 - I50 MSEK annually from 2002from 2002

Restructuring ProgramRestructuring Program

Divestiture of OrtoMaquetDivestiture of OrtoMaquet

Product development initiativesProduct development initiativesMarket penetration tables Market penetration tables USA + JapanUSA + Japan

I5 --> 30% market shares --> 250 I5 --> 30% market shares --> 250 MSEK+MSEK+

Cross-selling opportunities in most Cross-selling opportunities in most marketsmarkets

Own sales companies in major marketsOwn sales companies in major marketsActive participation in the consolidation Active participation in the consolidation

of the surgical systems marketof the surgical systems market

Growth Opportunities in Surgical Growth Opportunities in Surgical SystemsSystems

Surgical systemsSurgical systemsMarket development Q1 (msek)Market development Q1 (msek)

2002 2001 Change 2002 2001 Change

per market Q 1 Q 1 3 Mon 3 MonUSA and Canada 112 100 12% 112 100 12%

Great Britain 55 46.2 18% 55 46.2 18%

Germany 137 149 -8% 137 149 -8%

Other W Europe 169 126 33% 169 126.4 33%

Rest of the world 187 120 56% 187 120 56%

Business area tot. 659 541 22% 659 541 22%

Surgical SystemsSurgical SystemsResults Q1 (msek)Results Q1 (msek)

2002 2001 2002 2001 2001Q 1 Q 1 3 Mon 3 Mon F Y

Net sales 518 556 518 556 2,223 Gross margin % 45.9% 47.8% 45.9% 47.8% 49.9%Operating cost -205 -205 -205 -205 -881 Operating profit 33 61 33 61 228 Operating margin % 6.3% 10.9% 6.3% 10.9% 10.3%

Getinge ABGetinge ABResults Results (Msek)(Msek)

2002 2001 Change 2002 2001 ChangeQ 1 Q 1 3 Mon 3 Mon

Orders received 2,168 1,986 9% 2,168 1,986 9%

Net sales 1,909 1,919 -1% 1,909 1,919 -1%EBITDA 284 315 -10% 284 315 -10%Operating profit 190 228 -17% 190 228 -17%Operating margin 9.9% 11.9% 9.9% 11.9%Profit before tax 146 167 -13% 146 167 -13%

Getinge ABGetinge ABBalance sheets Balance sheets (Msek)(Msek)Assets 2002-03-31 2001-03-31 2001-12-31Subscribed capital unpaid 490Intangible fixed assets 2 621 2 762 2 768Tangible fixed assets 1 283 1 336 1 341Financial assets 470 415 462Stock-in-trade 1 784 1 672 1 719Current receivables 2 702 2 688 2 935Liquid funds 398 377 364Total assets 9 259 9 740 9 589

Shareholders' equity & liabilitiesShareholders' equity 2 948 2 653 2 953Minority interests - 9 -Pension provisions, interest-bearing 1 050 1 033 1 090Restructuring reserve 129 581 149Other provisions 523 464 540Long-term liabilities 3 131 2 127 2 179Current liabilities 1 479 2 874 2 679Total Equity & Liabilities 9 259 9 740 9 589

Turnaround in the earnings trend for Turnaround in the earnings trend for Infection ControlInfection Control

Good overall order situation and Good overall order situation and market outlook for all business areasmarket outlook for all business areas

Incremental synergies in Incremental synergies in Surgical Surgical SystemsSystems

Improving capital utilizationImproving capital utilization

Getinge is well positionedGetinge is well positioned

Short termShort term

Strong market fundamentals in Strong market fundamentals in Extended CareExtended Care

Significant scope for improvement in Significant scope for improvement in operating performance within operating performance within Infection Infection

ControlControl

Opportunities for growth through Opportunities for growth through acquisitions in a fragmented acquisitions in a fragmented Surgical Surgical

SystemsSystems market market

Getinge is well positionedGetinge is well positioned

Long termLong term